No quarterly revenue total was found in Bone Biologics Corporation's SEC filings.
Bone Biologics Corporation (BBLG) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Revenue
—
Net income
$-617,651
+7.4% vs year-ago quarter
Operating cash flow
$-532,275
+10.0% vs year-ago quarter
Free cash flow
—
EPS
$-0.17
+54.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
3.39M
+88.8% vs year-ago quarter
Net cash
—
Operating margin
-0.1%
TTM
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- BBLG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1419554
- Former names
- Bone Biologics, Corp. (until Nov 2, 2015); AFH ACQUISITION X, INC. (until Sep 15, 2014)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$666,340 | -$808,106 | -$805,054 | -$733,105 | -$715,274 |
| Net income | -$617,651 | -$773,702 | -$765,988 | -$684,643 | -$666,737 |
| Diluted EPS | -$0.17 | -$0.43 | -$0.43 | -$0.38 | -$0.37 |
| Operating cash flow | -$532,275 | -$518,440 | -$804,282 | -$714,762 | -$591,384 |
| Total assets | $6.4M | $4.4M | $5.0M | $5.8M | $6.4M |
| Total liabilities | $480,775 | $512,018 | $309,386 | $418,587 | $334,282 |
| Stockholders' equity | $6.0M | $3.9M | $4.7M | $5.4M | $6.0M |
| Cash and investments | $6.1M | $4.0M | $4.5M | $5.3M | $6.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 26, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 29, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 16, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Other events
|
Jul 16, 2026 | Jul 15, 2026 |
All 485 Bone Biologics Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.